Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.30 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19511673 | 0.75 | LMNA (0.32) | LMNACA2 | |
| SCHEMBL28416093 | 0.75 | LMNA (0.32) | LMNACA2 | |
| SCHEMBL28413451 | 0.75 | LMNA (0.32) | LMNACA2 | |
| SCHEMBL28416438 | 0.75 | LMNA (0.32) | LMNACA2 | |
| SCHEMBL23437461 | 0.74 | TSHR (0.44) | LMNAPLA2G1BPLA2G2A | |
| SCHEMBL22096531 | 0.74 | TSHR (0.44) | LMNAPLA2G1BPLA2G2A | |
| SCHEMBL22401146 | 0.74 | TSHR (0.44) | LMNAPLA2G1BPLA2G2A | |
| SCHEMBL23437458 | 0.74 | TSHR (0.44) | LMNAPLA2G1BPLA2G2A | |
| SCHEMBL22401186 | 0.74 | TSHR (0.44) | LMNAPLA2G1BPLA2G2A | |
| SCHEMBL20882132 | 0.74 | TSHR (0.44) | LMNAPLA2G1BPLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070010004-A1 | Micellar systems | ROCHE MADISON INC. | 2007-01-11 | — | — | US | disclosed |
| US-7091041-B2 | Micellar systems | MIRUS BIO CORPORATION (US) | 2006-08-15 | — | — | US | disclosed |
| US-20040023393-A1 | Micellar systems | ROCHE MADISON INC. | 2004-02-05 | — | — | US | disclosed |
| US-6673612-B2 | GENERATION OF MICELLE FOR THE TRANSFER OF BIOPOLYMERS TO CELLS; FORM CATIONIC REVERSE MICELLE USING AMPHIPATHIC MOLECULES, INSERT BIPOLYMER, ADJUST THE CHARGE OF MICELLE , TRANSFER TO CELLS | MIRUS CORPORATION | 2004-01-06 | — | — | US | disclosed |
| US-20030027339-A1 | Micellar systems | ROCHE MADISON INC. | 2003-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010004-A1 | Micellar systems | POLRMT, NSUN3, NSUN2 | LMNA 192/4885PLA2G1B 1206/4885PLA2G2A 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.